74 results
Page 3 of 4
DEF 14A
8gr86zb
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
7y29x 1l8
14 Apr 20
Preliminary proxy
4:46pm
10-K
EX-10.16
bpzpqj
27 Feb 20
Annual report
4:02pm
10-K
wleq5qgg
27 Feb 20
Annual report
4:02pm
10-K
EX-10.15
ts2u7f1d
27 Feb 20
Annual report
4:02pm
10-K
EX-10.13
7w7ge
27 Feb 20
Annual report
4:02pm
10-K
EX-10.14
nbjqhx8hofdb2
27 Feb 20
Annual report
4:02pm
6-K
EX-99.1
sx0ibydna8atcis5qcs
6 Nov 19
Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting
4:07pm
6-K
EX-99.1
p1mjt2ne1f4mt
30 Jul 19
Three-Year Registrational Data Set to be Presented by Year End 2019
4:00pm
424B4
riqnv5xve7gzos nd
6 Jun 19
Prospectus supplement with pricing info
4:28pm
F-1
vu52bl
3 Jun 19
Registration statement (foreign)
4:33pm
DRS
q8dqcl
3 May 19
Draft registration statement
12:00am
20-F/A
EX-4.12
cso5b
26 Apr 19
Annual report (foreign) (amended)
4:54pm
6-K
EX-99.1
7nxlh p9o8j
25 Apr 19
Program on Track for MAA and BLA Regulatory Submissions in 2021
4:00pm
20-F
EX-4.3
t7uuqiskcq mv1l2c
22 Mar 19
Annual report (foreign)
8:02am
20-F
EX-4.12
19rr19h6
22 Mar 19
Annual report (foreign)
8:02am
20-F
x42eg7622y09
22 Mar 19
Annual report (foreign)
8:02am
20-F
EX-1.1
qd64ikdhrxyv
22 Mar 19
Annual report (foreign)
8:02am
6-K
EX-99.1
2pvnzkmqnb3d3fjek0
25 Feb 19
Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control from Registrational Trial of OTL-101 for the Treatment of ADA-SCID
12:00am
424B4
gyxfi0c3 8soq
31 Oct 18
Prospectus supplement with pricing info
4:36pm